Experimental data and PBPK modeling quantify antibody interference in PEGylated drug carrier delivery (Q2051453): Difference between revisions
From MaRDI portal
Changed an Item |
Set profile property. |
||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Revision as of 06:42, 5 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Experimental data and PBPK modeling quantify antibody interference in PEGylated drug carrier delivery |
scientific article |
Statements
Experimental data and PBPK modeling quantify antibody interference in PEGylated drug carrier delivery (English)
0 references
24 November 2021
0 references
PBPK model
0 references
Latin hypercube sampling
0 references
parameter optimization
0 references
anti-PEG antibodies
0 references
pegylated liposomes
0 references
